FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
Valerius T, Stockmeyer B, van Spriel AB, Graziano RF, van den Herik-Oudijk IE, Repp R, Deo YM, Lund J, Kalden JR, Gramatzki M, van de Winkel JG.
Valerius T, et al. Among authors: gramatzki m.
Blood. 1997 Dec 1;90(11):4485-92.
Blood. 1997.
PMID: 9373259
Free article.